Patent · US Active

Sanglifehrin based compounds

US9119853B2 · kind B2 · utility

7Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 9, 2011
Grant dateSep 1, 2015
Priority date—
Expiry dateApr 13, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are provided inter alia compounds of formula (I)useful as cyclophilin inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.